Stiptik
FDA Label NDC 66915-301

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Island Kinetics, Inc. D.b.a. Covalence Laboratories for the product Stiptik (NDC 66915-301). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding dosage & administration section, principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Dosage & Administration Section

→ Principal Display Panel

Dosage & Administration Section

* Please review the disclaimer below.

Previous Product 66915-301

Next Product 66915-438